Takeda Pharmaceutical Company Limited
SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF
Last updated:
Abstract:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
Status:
Application
Type:
Utility
Filling date:
21 Jan 2021
Issue date:
17 Mar 2022